New Medicine Service (NMS)

The New Medicine Service (NMS) provides support for people with long-term conditions newly prescribed a medicine to help improve medicines adherence; it is focused on specific patient groups and conditions.

For more information please visit the CPE website.

Forthcoming changes to the service

Developments in NMS IT support planned for December 2023

From a date to be determined, subject to positive evaluation of an ongoing pilot, the NMS will expand to include antidepressants to enable patients who are newly prescribed an antidepressant to receive extra support from their community pharmacist.

Further details on this change will be published in due course.